NEW YORK (Reuters Health) Jun 24 –
Lamivudine effectively suppresses hepatitis B virus (HBV) DNA levels, whereas amciclovir
is significantly less effective, according to a report in the July Journal of Medical Virology.
Significant resistance emerges during treatment of HBV infection with lamivudine, the authors
explain, and in vitro studies suggest that famciclovir and lamivudine could synergistically
inhibit HBV replication.
תגובות רוצה להצטרף לדיון?
יש להתחבר כדי להגיב.
התחבראין תגובות עדיין. היה הראשון להגיב!